A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer
PHASE2
The primary purpose of this study is to determine if sapanisertib in combin...
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
PHASE2
This is a Phase 2, multicenter, open-label, single-arm study to evaluate th...